Medicus Pharma Ltd. MDCX.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.51% | 13.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.52% | 10.35% | |||
| Operating Income | -33.52% | -10.35% | |||
| Income Before Tax | -29.22% | 39.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.22% | 39.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 33,250.00% | 100.00% | |||
| Net Income | -28.48% | 39.99% | |||
| EBIT | -33.52% | -10.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 31.06% | 62.21% | |||
| Normalized Basic EPS | 30.32% | 62.44% | |||
| EPS Diluted | 31.06% | 62.21% | |||
| Normalized Diluted EPS | 30.32% | 62.44% | |||
| Average Basic Shares Outstanding | 86.37% | 58.82% | |||
| Average Diluted Shares Outstanding | 86.37% | 58.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||